Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03438318
Title Study Evaluating CMP-001 in Combination With Atezolizumab in Subjects With Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Checkmate Pharmaceuticals

lung non-small cell carcinoma


Atezolizumab + Vidutolimod

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.